Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil

NCT01514734 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Low recruitment rate

Conditions

Glaucoma

Interventions

DRUG: Brinzolamide/timolol maleate fixed combination

Sponsor

Alcon Research